J.P. Morgan discloses Kangji Medical shares dealings

J.P. Morgan Securities PLC, an associate connected with the offeror for Kangji Medical Holdings Limited, has disclosed dealings in the company's shares. On October 15, 2025, J.P. Morgan Securities PLC reported two sale transactions for its own account, totaling 4,000 shares.

The first sale involved 2,000 shares for a total of $17,803.70, with prices ranging from a high of $8.92 to a low of $8.91. The second sale also comprised 2,000 shares, yielding a total of $17,798.70, with both the highest and lowest prices recorded at $8.91.

These transactions were described as "Other types of securities (e.g. equity swaps)" and were related to "Hedging of Delta 1 products created as a result of wholly unsolicited client-driven orders." J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.